The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 27256913 |
28 |
Discovery of indole inhibitors of chemokine receptor 9 (CCR9). |
Cubist Pharmaceuticals |
| 26117562 |
51 |
Biarylsulfonamide CCR9 inhibitors for inflammatory bowel disease. |
Cubist Pharmaceuticals |
| 22931505 |
69 |
Chemokine receptor antagonists. |
National Heart and Lung Institute |
| 31703817 |
2 |
Discovery of small-molecule candidates against inflammatory bowel disease. |
Zhejiang University |
| 26987013 |
96 |
A New Series of Orally Bioavailable Chemokine Receptor 9 (CCR9) Antagonists; Possible Agents for the Treatment of Inflammatory Bowel Disease. |
Norgine |
| 29406702 |
128 |
Discovery of Novel 1-Cyclopentenyl-3-phenylureas as Selective, Brain Penetrant, and Orally Bioavailable CXCR2 Antagonists. |
Gsk Pharmaceuticals R & D |
| 8719416 |
17 |
Cloning and characterization of the human GABAA receptor alpha 4 subunit: identification of a unique diazepam-insensitive binding site. |
Cocensys |
Search and Browse
